IMPAX LABS FDA Approval ANDA 085098

ANDA 085098

IMPAX LABS

FDA Drug Application

Application #085098

Application Sponsors

ANDA 085098IMPAX LABS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL100MG0HYDROCHLOROTHIAZIDEHYDROCHLOROTHIAZIDE

FDA Submissions

ORIG1AP1977-07-15
LABELING; LabelingSUPPL16AP1991-09-18
LABELING; LabelingSUPPL20AP1989-11-09
LABELING; LabelingSUPPL21AP1990-01-23
LABELING; LabelingSUPPL22AP1990-04-06
LABELING; LabelingSUPPL23AP1991-01-16
LABELING; LabelingSUPPL24AP2001-03-16
LABELING; LabelingSUPPL25AP2001-03-16

CDER Filings

IMPAX LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 85098
            [companyName] => IMPAX LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.